BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36225179)

  • 21. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
    Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
    J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
    Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
    DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis.
    Xiong J; Guo S; Bing Z; Su Y; Guo L
    Front Genet; 2018; 9():696. PubMed ID: 30662454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor purity as a prognosis and immunotherapy relevant feature in cervical cancer.
    Deng Y; Song Z; Huang L; Guo Z; Tong B; Sun M; Zhao J; Zhang H; Zhang Z; Li G
    Aging (Albany NY); 2021 Nov; 13(22):24768-24785. PubMed ID: 34844217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic prediction using a gene signature developed based on exhausted T cells for liver cancer patients.
    Zhou Y; Wu W; Cai W; Zhang D; Zhang W; Luo Y; Cai F; Shi Z
    Heliyon; 2024 Mar; 10(6):e28156. PubMed ID: 38533068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L
    Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164
    [No Abstract]   [Full Text] [Related]  

  • 28. Methylation-driven genes and their prognostic value in cervical squamous cell carcinoma.
    Liu J; Nie S; Li S; Meng H; Sun R; Yang J; Cheng W
    Ann Transl Med; 2020 Jul; 8(14):868. PubMed ID: 32793712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of candidate miRNA biomarkers correlated with the prognosis of cell carcinoma and endocervical adenocarcinoma via integrated bioinformatics analysis.
    Zhi S; Jiang B; Yu W; Li Y; Wang H; Zhou T; Li N
    Am J Transl Res; 2022; 14(11):8146-8155. PubMed ID: 36505295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a four-mRNA prognostic signature with its ceRNA network in CESC.
    Li L; Guo Q; Lan G; Liu F; Wang W; Lv X
    Sci Rep; 2022 Jun; 12(1):10691. PubMed ID: 35739227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas.
    Lin Z; Zou J; Sui X; Yao S; Lin L; Wang J; Zhao J
    Sci Rep; 2022 Sep; 12(1):16285. PubMed ID: 36175606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
    Dong Y; Wen W; Yuan T; Liu L; Li X
    Dis Markers; 2023; 2023():1766080. PubMed ID: 36817087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening of Significant Biomarkers Related to Prognosis of Cervical Cancer and Functional Study Based on lncRNA-associated ceRNA Regulatory Network.
    Ding H; Zhang L; Zhang C; Song J; Jiang Y
    Comb Chem High Throughput Screen; 2021; 24(3):472-482. PubMed ID: 32729415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
    Wang Y; Zhang L; Wang B; Cheng Y
    Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cellular senescence-related genes model allows for prognosis and treatment stratification of cervical cancer: a bioinformatics analysis and external verification.
    Yang W; An L; Li Y; Qian S
    Aging (Albany NY); 2023 Sep; 15(18):9408-9425. PubMed ID: 37768206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma.
    Yang F; Zhou LQ; Yang HW; Wang YJ
    Front Genet; 2022; 13():927614. PubMed ID: 36092911
    [No Abstract]   [Full Text] [Related]  

  • 38. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer.
    Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y
    Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer.
    Wang J; Wang S; Wang J; Huang J; Lu H; Pan B; Pan H; Song Y; Deng Q; Jin X; Shi G
    Cancer Med; 2023 Dec; 12(24):22381-22394. PubMed ID: 38087815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Typing Based on Oxidative Stress Genes and Establishment of Prognostic Characteristics of 7 Genes in Lung Adenocarcinoma.
    Tu J; Tang M; Li G; Chen L; Huang Y
    Oxid Med Cell Longev; 2022; 2022():9683819. PubMed ID: 36148413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.